Two-year PAD-related health care costs in patients undergoing lower extremity endovascular revascularization: Results from the LIBERTY 360 ° trial

Conclusions: Among patients with symptomatic lower extremity PAD undergoing endovascular revascularization, initial treatment costs and total 2-year costs vary significantly according to symptom burden and clinical and lesion-level characteristics.PMID:33866936 | DOI:10.1080/13696998.2021.1917141

Source: Journal of Medical Economics - April 19, 2021 Category: Health Management Authors: Elizabeth A Magnuson Haiyan Li Katherine Vilain Ehrin J Armstrong Eric A Secemsky Stefanos Giannopoulos George L Adams Jihad Mustapha David J Cohen LIBERTY 360 ° Trial Investigators Source Type: research